Venue: The Open University, Milton Keynes (MK7 6AA).
Date: 25/06/2019.
Scientific Committee: Prof. YZ Wang, University of British Columbia; Prof. Hardev Pandha, University of Surrey; Dr Francesco Crea, The Open University; Dr Rebecca Mather, The Open University.
This meeting is accredited by the CPD Standards Office and is worth 5 hours CPD.
Watch videos of the conference presentations here;
Part 1 (session 1 speakers)
Part 2 (session 1 panel discussion)
Part 3 (session 2 speakers)
9:00-10:00 Registration (tea, coffee, biscuits)
Session 1 : CLINICAL ASPECTS OF TREATMENT-EMERGENT NEUROENDOCRINE PROSTATE CANCER
Session Chair: Dr Sushila Rigas, The Open University.
10-10.15 Welcome.
Dr Martin Bootman, Director of Research LHCS, The Open University
10.15-11:00 The clinical progression of prostate cancer
Prof Hardev Pandha, Director of Surrey Cancer Centre.
11:00-11.30 Clinical characterization of treatment-emergent NEPC
Dr Francesco Crea, The Open University
11.30-12.30 Panel discussion: treatment-emergent NEPC: a new challenge for clinicians and researchers.
Dr Mark Eccleston, Volition; Mr Henry Andrews, Milton Keynes hospital (Urology); Prof Hardev Pandha, Surrey Cancer Centre; Dr Francesco Crea, The Open University
12.30-2.00 Lunch and poster session
Session 2 : MOLECULAR MECHANSISMS OF NEUROENDOCRINE TRANS-DIFFERENTIATION.
Session Chair: Dr Mario Colombo, Italian National Cancer Institute
2.00-2.45 The nature of neuroendocrine trans-differentiation: lessons learned from patient-derived xenografts.
Prof YZ Wang, BC Cancer Agency, Canada.
2.45-3.15 The long non-coding RNA landscape of neuroendocrine prostate cancer.
Dr Rebecca Mather, The Open University.
3.15-3.45 The role of tumour microenvironment in neuroendocrine prostate cancer.
Dr Elena Jachetti, Italian National Cancer Institute.
4.00-4.30 Feedback opportunity
4.30-6:00
Networking(tea, coffee, biscuits)